In patients with obstructive jaundice, biliary decompression can be achieved by an endoprosthesis inserted by a percutaneous transhepatic approach. The prosthesis sometimes becomes dislodged and thus additional percutaneous transhepatic procedures may be required. To avoid this problem, a nondislodgeable endoprosthesis has been developed. The prosthesis is constructed with a layer of biocompatible material (hydrogel) on its surface. The hydrogel is located in grooves around the endoprosthesis and has the ability to absorb liquid, which increases its size. By placing the rings of hydrogel on either side of the obstruction, dislodgement of the prosthesis can be prevented. The nondislodgeable endoprosthesis has been inserted into 11 patients with biliary obstructions due to malignant strictures. No 
Patients and Methods
Eleven consecutive jaundiced patients with a median age of 76 years (range 52-83) were included because they needed either a permanent palliative shunt or a temporary procedure before surgical treatment. The diagnosis was carcinoma of the bile ducts or gall bladder in six cases and carcinoma of the pancreas in five cases. The diagnoses were confirmed in all patients either by a fine needle biopsy or at operation.
The PTC procedure was carried out under fluoroscopic control according to the technique described by Wiechel 1964.' The procedure was performed under general anesthesia, with apnoea in the midinspiratory position in order to minimize the risk of the catheter being fed out during or after the investigation. The puncture with a PTC instrument (Wiechel-Stille, Stockholm, Sweden), was performed in the mid-axillary-line on the right side, with the quidance of the pleural sinus, the lower contour of the liver, and the possible presence of gas in the duodenal bulb often in the direction to vertebrae Th XI-Th XII. After puncture of an intrahepatic bile duct and withdrawal of the mandrin, a small amount of contrast medium (Isopaque 150 mg I/ml, Nyegaard and Co. A/S, Oslo, Norway) was injected before the catheter was secured by the guide-wire technique. Subsequently, another more peripheral intrahepatic bile duct was punctured and, after contrast medium injection through the secured catheters, a flexible guide-wire (PE 160, Surgimed A/S, Denmark) was passed through the obstruction. A polyethylene catheter (PE 205) was passed lidone), containing a cross-binding triacrylate, was graftpolymerized into the grooves of the PVC tube by radiation (60Co 450 krad/h during 2 h). The endoprosthesis was then sterilized (3.2 Mrad during 10-12 h), which at the same time causes a complete hardening of the polymer. This procedure has been developed in collaboration with T. Reitberger, Dr. Techn., at the Department of Nuclear Chemistry, Royal Institute of Technology, Stockholm, Sweden. This technique has been used in the present study but the endoprosthesis will in the future be commercially available (Astra Meditec, Molndal, Sweden).
The surface of the endoprosthesis has the same diameter along the whole of its length during the percutaneous, transhepatic passage to the obstructed area. The two bands of hydrogel give the endoprosthesis a unique property, since the hydrogel increases in size by absorbing bile, thus rising above the surface of the prosthesis (Fig. 1) . This fixes the prosthesis with one hydrogel band on each side of an obstruction, as can be seen in Fig. 2 . over this guide-wire and the PE 160 guide-wire was replaced by a PE 205 guide-wire, over which the endoprosthesis was inserted by means of an introducer having the same diameter as the endoprosthesis.
The prototype of the endoprosthesis (length 10 cm, inner diameter 2 mm, outer diameter 3 mm) consists of a flexible radiopaque polyvinylchloride (PVC) tube (Surgimed A/S, Denmark) with side holes. 
Results
The insertion of the endoprosthesis was successful in all patients. In four cases the introduction of the prosthesis was carried out 3 to 5 days after the PTC procedure, since cannulation of the tumor area was not possible at the first attempt due to edematous swelling ar'ound the tumor with a dilated choledochus. One patient had two endoprostheses inserted within 2 days as two segments of the liver needed separate drainage. 4~~~~~~~~T he plasma bilirubin concentrations returned to normal within 2 to 3 weeks, regardless of the initial degree of jaundice (Fig. 3) . The [3] [4] [5] [6] [7] intrahepatic bile ducts. months).
VOl. 201.- NO. 3 the head of the pancreas (Fig. 6) . The endoprosthesis was introduced, over a guide-wire, with its hydrogel rings above and below the tumor (Fig. 7) . After 3 weeks the patient was anicteric and the bile ducts were normalized (Fig. 8) . She subsequently underwent a Whipple procedure.
Discussion
The outlook for patients with carcinoma of the pancres r f the biliary tree is poor, with a resectability rate of about 20%13 Therefore the majority of such patients may only need a palliative procedure. PTC is a procedure, with a good chance of making a correct -U M:M! _ l diagnosis, that carries little risk of complications.8 '9 Cholangitis is often described as a complication of the PTC procedure and has been reported to occur in 20% of cases. ' (Fig. 4) . After the passage of a guidewire and a catheter, an endoprosthesis was inserted, with normalization of the dilated intrahepatic bile ducts (Fig. 5 ). There was a fall in plasma bilirubin levels, together with a disappearance of the pruritus. The patient was discharged from the hospital and went back to work. can occur, namely dislodgement. In our material no dislodgement occurred, and there was no permanent obstruction of the endoprosthesis. This "nondislodgeable" endoprosthesis may therefore be used either before surgery or as a definitive palliative procedure to reduce the bilirubin serum levels and to restore the enterohepatic circulation, since the majority of tumors in this area will not be resected. It is also possible to load the hydrogel with an antibiotic or a chemotherapeutic agent before insertion of the prosthesis in order to obtain a local antibacterial effect in the bile.
By introducing an endoprosthesis at the same time that the PTC procedure is carried out, an unnecessary intraoperative bypass procedure with a high mortality risk can thus be avoided. The aim in this patient group must be to relieve jaundice and pruritus and to reduce pain and anorexia, which will improve the patients' general condition and reduce the time spent in hospital.
